Literature DB >> 21602301

Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.

Jeremy A Rassen1, Robert J Glynn, M Alan Brookhart, Sebastian Schneeweiss.   

Abstract

To reduce bias by residual confounding in nonrandomized database studies, the high-dimensional propensity score (hd-PS) algorithm selects and adjusts for previously unmeasured confounders. The authors evaluated whether hd-PS maintains its capabilities in small cohorts that have few exposed patients or few outcome events. In 4 North American pharmacoepidemiologic cohort studies between 1995 and 2005, the authors repeatedly sampled the data to yield increasingly smaller cohorts. They identified potential confounders in each sample and estimated both an hd-PS that included 0-500 covariates and treatment effects adjusted by decile of hd-PS. For sensitivity analyses, they altered the variable selection process to use zero-cell correction and, separately, to use only the variables' exposure association. With >50 exposed patients with an outcome event, hd-PS-adjusted point estimates in the small cohorts were similar to the full-cohort values. With 25-50 exposed events, both sensitivity analyses yielded estimates closer to those obtained in the full data set. Point estimates generally did not change as compared with the full data set when selecting >300 covariates for the hd-PS. In these data, using zero-cell correction or exposure-based covariate selection allowed hd-PS to function robustly with few events. hd-PS is a flexible analytical tool for nonrandomized research across a range of study sizes and event frequencies.

Entities:  

Mesh:

Year:  2011        PMID: 21602301      PMCID: PMC3145392          DOI: 10.1093/aje/kwr001

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  40 in total

1.  Quantifying biases in causal models: classical confounding vs collider-stratification bias.

Authors:  Sander Greenland
Journal:  Epidemiology       Date:  2003-05       Impact factor: 4.822

2.  Approaches to combat with confounding by indication in observational studies of intended drug effects.

Authors:  Alex D McMahon
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003 Oct-Nov       Impact factor: 2.890

3.  What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.

Authors:  Michael J Sweeting; Alexander J Sutton; Paul C Lambert
Journal:  Stat Med       Date:  2004-05-15       Impact factor: 2.373

4.  The case-crossover design: a method for studying transient effects on the risk of acute events.

Authors:  M Maclure
Journal:  Am J Epidemiol       Date:  1991-01-15       Impact factor: 4.897

5.  Toward a clearer definition of confounding.

Authors:  C R Weinberg
Journal:  Am J Epidemiol       Date:  1993-01-01       Impact factor: 4.897

6.  Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.

Authors:  J Simes; C D Furberg; E Braunwald; B R Davis; I Ford; A Tonkin; J Shepherd
Journal:  Eur Heart J       Date:  2002-02       Impact factor: 29.983

7.  Spurious effects from an extraneous variable.

Authors:  I D Bross
Journal:  J Chronic Dis       Date:  1966-06

8.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

9.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors:  C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

10.  Evaluating medication effects outside of clinical trials: new-user designs.

Authors:  Wayne A Ray
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897

View more
  74 in total

1.  High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications.

Authors:  E Garbe; S Kloss; M Suling; I Pigeot; S Schneeweiss
Journal:  Eur J Clin Pharmacol       Date:  2012-07-05       Impact factor: 2.953

2.  Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques.

Authors:  Jessica M Franklin; William H Shrank; Joyce Lii; Alexis K Krumme; Olga S Matlin; Troyen A Brennan; Niteesh K Choudhry
Journal:  Health Serv Res       Date:  2015-04-16       Impact factor: 3.402

3.  Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study.

Authors:  Seoyoung C Kim; Sebastian Schneeweiss; Niteesh Choudhry; Jun Liu; Robert J Glynn; Daniel H Solomon
Journal:  Am J Med       Date:  2015-02-03       Impact factor: 4.965

4.  Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system.

Authors:  Patrick B Ryan; Martijn J Schuemie; Susan Gruber; Ivan Zorych; David Madigan
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

5.  The Association Between Use of Chiropractic Care and Costs of Care Among Older Medicare Patients With Chronic Low Back Pain and Multiple Comorbidities.

Authors:  William B Weeks; Brent Leininger; James M Whedon; Jon D Lurie; Tor D Tosteson; Rand Swenson; Alistair J O'Malley; Christine M Goertz
Journal:  J Manipulative Physiol Ther       Date:  2016-02-19       Impact factor: 1.437

6.  Acute renal failure in patients treated with dronedarone or amiodarone: a large population-based cohort study in Italy.

Authors:  Valentino Conti; Chiara Biagi; Mauro Melis; Ida Fortino; Monia Donati; Alberto Vaccheri; Mauro Venegoni; Domenico Motola
Journal:  Eur J Clin Pharmacol       Date:  2015-07-15       Impact factor: 2.953

7.  Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.

Authors:  Krista F Huybrechts; Kenneth J Rothman; Rebecca A Silliman; M Alan Brookhart; Sebastian Schneeweiss
Journal:  CMAJ       Date:  2011-03-28       Impact factor: 8.262

8.  Plasmode simulation for the evaluation of pharmacoepidemiologic methods in complex healthcare databases.

Authors:  Jessica M Franklin; Sebastian Schneeweiss; Jennifer M Polinski; Jeremy A Rassen
Journal:  Comput Stat Data Anal       Date:  2014-04       Impact factor: 1.681

9.  Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs.

Authors:  T Stürmer; R Wyss; R J Glynn; M A Brookhart
Journal:  J Intern Med       Date:  2014-02-13       Impact factor: 8.989

10.  A comparison of confounding adjustment methods for assessment of asthma controller medication effectiveness.

Authors:  Lingling Li; William M Vollmer; Melissa G Butler; Pingsheng Wu; Elyse O Kharbanda; Ann Chen Wu
Journal:  Am J Epidemiol       Date:  2014-01-23       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.